Cargando…
The focus clinical research in intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC), highly invasive and highly heterogeneous, has a poor prognosis. It has been confirmed that many risk factors are associated with ICC including intrahepatic lithiasis, primary sclerosing cholangitis (PSC), congenital abnormalities of the bile ducts, parasite inf...
Autores principales: | Song, Yinghui, Cai, Mengting, Li, Yuhang, Liu, Sulai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277934/ https://www.ncbi.nlm.nih.gov/pubmed/35820926 http://dx.doi.org/10.1186/s40001-022-00741-9 |
Ejemplares similares
-
Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022) -
Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022) -
The new insight of treatment in Cholangiocarcinoma
por: Li, Yuhang, et al.
Publicado: (2022) -
Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
por: Ding, Bai, et al.
Publicado: (2023) -
MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma
por: Chen, Chen, et al.
Publicado: (2020)